Surgery, tamoxifen, carboplatin, and radiotherapy in the treatment of newly diagnosed glioblastoma patients.
- 1 January 2000
- journal article
- clinical trial
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 49 (2) , 147-155
- https://doi.org/10.1023/a:1026533016912
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Tamoxifen radiosensitization in human glioblastoma cell linesJournal of Neurosurgery, 1999
- Radiation response and survival time in patients with glioblastoma multiformeJournal of Neurosurgery, 1996
- Early Postoperative Magnetic Resonance Imaging after Resection of Malignant Glioma: Objective Evaluation of Residual Tumor and Its Influence on Regrowth and PrognosisNeurosurgery, 1994
- Protein Kinase C Inhibitors Suppress Cell Growth in Established and Low-Passage Glioma Cell Lines. A Comparison between Staurosporine and TamoxifenNeurosurgery, 1993
- Resection, biopsy, and survival in malignant glial neoplasmsJournal of Neurosurgery, 1993
- Clinical and Radiographic Response in a Minority of Patients with Recurrent Malignant Gliomas Treated with High-Dose TamoxifenNeurosurgery, 1993
- Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase CScience, 1992
- Enhancement of Radiosensitivity by Tamoxifen in C6 Glioma CellsNeurosurgery, 1992
- Protein Kinase C Activity Correlates with the Growth Rate of Malignant GliomasNeurosurgery, 1992
- The Treatment of Intracranial Malignant Gliomas Using Orally Administered Tamoxifen TherapyNeurosurgery, 1992